Experimental pill effective in treating third of leukemia patients in phase I trial
The pill, revumenib, has shown benefit in treating both adults and children with certain type of acute leukemia.
Progestin-only contraceptive use increases breast cancer risk similarly to combined contraceptive use.
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
An estimated 40,000 Somalians may have died last year in a drought caused by the failure of six consecutive rainy seasons, a new
About 800,000 people die yearly from diseases directly linked to unsafe water, inadequate sanitation, poor hygiene practices, and water-related hazards have increased at
The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs